UVA Tracking #
Stephen H Caldwell
Official Trial Title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2b/3 Study to Evaluate the Efficacy and Safety of Saroglitazar Magnesium in Subjects with Primary Biliary Cholangitis
The Gastroenterology and Hepatology seeks adults ages 18 to 75 with Primary Biliary Cholangitis (PBC) for a research study. The purpose of the study is to see if a new drug (sarogliazar) is effective at improving the lab results for patients with PBC.
Study involves taking an experimental medicine/placebo daily, blood draws, fibroscan, EKGs, and abdominal ultrasounds. This study involves at least 15 visits at UVA over approximately 59 weeks. Each visit lasting about 1 1/2 hours.
Study-related (insert exams, tests and experimental medication) provided free of charge.